Literature DB >> 7507492

Expression and modulation of CD44 variant isoforms in humans.

C R Mackay1, H J Terpe, R Stauder, W L Marston, H Stark, U Günthert.   

Abstract

CD44 is a ubiquitous surface molecule that exists as a number of isoforms, generated by alternative splicing of 10 "variant" exons. Little is known about the expression and function of the variant isoforms, except that certain isoforms may play a role in cancer metastasis. We produced mAbs against CD44 variant regions encoded by exons 4v, 6v, and 9v, by immunizing mice with a fusion protein spanning variant exons 3v to 10v. A comprehensive analysis of human tissues revealed that CD44 variant isoforms were expressed widely throughout the body, principally by epithelial cells. However there was differential expression of CD44 variant exons by different epithelia. Most epithelia expressed exon 9v, but much fewer expressed 6v or 4v. The regions of epithelia that expressed the highest levels of the variant isoforms were the generative cells, particularly the basal cells of stratified squamous epithelium, and of glandular epithelium. CD44 variant isoforms were also expressed differentially by leukocytes, with CD44-9v expressed at very low levels and CD44-6v and 4v virtually absent. However, CD44-9v and CD44-6v were the main variants that were transiently upregulated on T cells after mitogenic stimulation and on myelomonocytic cell lines by TNF alpha and IFN gamma treatment. Some epithelial cell lines could preferentially upregulate CD44-6v upon IFN gamma incubation. These results show that CD44 variant isoforms are expressed much more widely than first appreciated, and that expression of the variant isoforms on some cell types can be modulated by particular cytokines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507492      PMCID: PMC2119889          DOI: 10.1083/jcb.124.1.71

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  63 in total

Review 1.  Tumour necrosis factor: roles in cancer pathophysiology.

Authors:  S T Malik
Journal:  Semin Cancer Biol       Date:  1992-02       Impact factor: 15.707

2.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell.

Authors:  H Cheng; C P Leblond
Journal:  Am J Anat       Date:  1974-12

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

5.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

Authors:  K K Tanabe; L M Ellis; H Saya
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

6.  Participation in normal immune responses of a metastasis-inducing splice variant of CD44.

Authors:  R Arch; K Wirth; M Hofmann; H Ponta; S Matzku; P Herrlich; M Zöller
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

7.  Prevention of tumor metastasis formation by anti-variant CD44.

Authors:  S Seiter; R Arch; S Reber; D Komitowski; M Hofmann; H Ponta; P Herrlich; S Matzku; M Zöller
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

8.  Tumor necrosis factor stimulates epithelial tumor cell motility.

Authors:  E M Rosen; I D Goldberg; D Liu; E Setter; M A Donovan; M Bhargava; M Reiss; B M Kacinski
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

9.  Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.

Authors:  K Miyake; C B Underhill; J Lesley; P W Kincade
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.

Authors:  M Salmi; K Grön-Virta; P Sointu; R Grenman; H Kalimo; S Jalkanen
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

View more
  104 in total

1.  The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4.

Authors:  E Stickeler; S D Fraser; A Honig; A L Chen; S M Berget; T A Cooper
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

2.  CD44 variant exons in leukemia and lymphoma.

Authors:  Elif Akisik; Sevil Bavbek; Nejat Dalay
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

3.  Expression of adhesion molecule CD44 on human corneas.

Authors:  S N Zhu; B Nölle; G Duncker
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

4.  Neutrophil migration across intestinal epithelium: evidence for a role of CD44 in regulating detachment of migrating cells from the luminal surface.

Authors:  Jennifer C Brazil; Winston Y Lee; Keli N Kolegraff; Asma Nusrat; Charles A Parkos; Nancy A Louis
Journal:  J Immunol       Date:  2010-10-25       Impact factor: 5.422

5.  Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma.

Authors:  T Nozoe; S Kohnoe; T Ezaki; A Kabashima; Y Maehara
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-11       Impact factor: 4.553

6.  Isolation and characterisation of antibodies which specifically recognise the peptide encoded by exon 7 (v2) of the human CD44 gene.

Authors:  A Borgya; A Woodman; M Sugiyama; F Donié; E Kopetzki; Y Matsumura; D Tarin
Journal:  Clin Mol Pathol       Date:  1995-10

7.  Crystallographic characterization of the radixin FERM domain bound to the cytoplasmic tail of adhesion molecule CD44.

Authors:  Tomoyuki Mori; Ken Kitano; Shin-ichi Terawaki; Ryoko Maesaki; Toshio Hakoshima
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-09-19

8.  Role of sialidase in Mycoplasma alligatoris-induced pulmonary fibroblast apoptosis.

Authors:  Marguerite E Hunt; Daniel R Brown
Journal:  Vet Microbiol       Date:  2006-10-17       Impact factor: 3.293

9.  The CD44 receptor is a molecular predictor of survival in ovarian cancer.

Authors:  L Rodríguez-Rodríguez; I Sancho-Torres; C Mesonero; D G Gibbon; W J Shih; G Zotalis
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

10.  Expression of CD44 on rheumatoid synovial fluid lymphocytes.

Authors:  D Kelleher; A Murphy; N Hall; M B Omary; G Kearns; A Long; E B Casey
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.